Pricing Log in Create free account

Enlivex Ltd. (ENLV) vs Silexion Therapeutics Corp (SLXN)

Enlivex Ltd. and Silexion Therapeutics Corp are both Biotechnology companies. Silexion Therapeutics Corp is the larger, with a market value of $2.2M against $2.0M — 1.1× the size. Silexion Therapeutics Corp has negative trailing earnings, so its P/E is not meaningful; Enlivex Ltd. trades at 0.0×. Across the 11 metrics below, Enlivex Ltd. leads on 7 and Silexion Therapeutics Corp on 4.

Valuation

Metric ENLV SLXN Biotechnology median
P/E 0.00 n/m 10.60
P/S n/m n/m 9.40
P/B 0.00 2.19 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 240.80 0.04 0.66
EV/Sales n/m n/m 9.02
Earnings yield 657,517.54% (40,328.57%) (32.88%)
Free cash flow yield (798.45%) (12,933.04%) (23.13%)

Profitability

Metric ENLV SLXN Biotechnology median
Gross margin 0.00% — 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 159.77% (17,021.95%) (51.96%)
Return on assets 127.16% (277.96%) (46.06%)
Return on invested capital (5.85%) 0.00% 0.00%

Growth

Metric ENLV SLXN Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 3,580.76% 97.73% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric ENLV SLXN Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 119.39 0.94 4.97
Net debt to EBITDA 118.29 0.38 1.01

Dividend

Metric ENLV SLXN Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric ENLV SLXN Biotechnology median
Market cap 1.95m 2.19m 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack